ACAD
31.07
-0.15
-0.48%
AEMD
0.25
-0.01
-4.48%
APRI
1.42
+0.09
+6.99%
ARNA
4.5
-0.06
-1.32%
ATEC
1.3
0.00
0.00%
CFN
59.59
+0.03
+0.04%
CNAT
5.98
+0.19
+3.28%
CRXM
0.21
0.00
0.00%
CYTX
0.48
0.00
0.00%
DXCM
61
+0.41
+0.68%
GNMK
13.3
+0.19
+1.45%
HALO
14.59
+0.44
+3.07%
ILMN
200.01
+2.15
+1.09%
INNV
0.21
+0.01
+4.95%
INO
8.5
0.00
0.00%
ISCO
0.06
+0.00
+7.83%
ISIS
69.88
+1.3
+1.90%
LGND
56.88
-0.54
-0.94%
LPTN
2.79
-0.1
-3.46%
MBVX
1.05
-0.1
-8.70%
MEIP
3.84
+0.12
+3.23%
MNOV
3.8
+0.01
+0.26%
MRTX
21.34
+0.88
+4.30%
MSTX
0.43
-0.02
-3.98%
NBIX
34.29
+0.9
+2.70%
NUVA
47.28
+0.81
+1.74%
ONCS
0.37
-0.02
-5.19%
ONVO
6.68
+0.19
+2.93%
OREX
5.34
-0.16
-2.82%
OTIC
31.75
+0.02
+0.06%
QDEL
24.45
+0.09
+0.37%
RCPT
112.71
-0.36
-0.32%
RGLS
18.63
+0.97
+5.49%
RMD
63.09
-0.23
-0.36%
SCIE
0.01
0.00
-9.60%
SPHS
0.47
+0.03
+6.59%
SRNE
10.73
+0.34
+3.27%
TROV
5.83
-0.02
-0.34%
VICL
1.05
+0.02
+1.46%
VOLC
17.98
+0.02
+0.11%
ZGNX
1.37
-0.02
-1.09%
Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

The Scripps Research Institute Scientists Uncover New, Fundamental Mechanism For How Resveratrol Provides Health Benefits

December 21, 2014 – 5:00 pm | Edit Post

LA JOLLA, Calif. and JUPITER, Fla., Dec. 22, 2014 /PRNewswire-USNewswire/ — Scientists at The Scripps Research Institute (TSRI) have found that resveratrol, the red-wine ingredient once touted as an elixir of youth, powerfully activates an evolutionarily…

Receptos Initiates SUNBEAM Phase 3 Trial Of RPC1063 In Relapsing Multiple Sclerosis

December 21, 2014 – 5:00 pm | Edit Post

Following Positive Phase 2 Results, Receptos Now Enrolling Two Phase 3 Trials in Relapsing Multiple Sclerosis Receptos Well Capitalized to Advance Clinical Development Program SAN DIEGO, Dec. 22, 2014 (GLOBE NEWSWIRE…

Sevion Announces Antibody Discovery Collaboration With Johnson & Johnson Innovation And Janssen Pharmaceutical Inc.

December 21, 2014 – 5:00 pm | Edit Post

Sevion Announces Antibody Discovery Collaboration with Johnson & Johnson Innovation and JanssenSAN DIEGO–(BUSINESS WIRE)–Sevion Therapeutics Inc. (“Sevion” or the “Company”) (OTCQB:SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics, today announced a collaboration agreement with CNA Development, LLC, an…

MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Reaches Response Milestone In Phase 2 Clinical Trial Of Pracinostat In Refractory Myelodysplastic Syndrome

December 21, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 22, 2014 /PRNewswire/ –MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced that the clinical response milestone has been reached in the Company’s ongoing Phase II study of its investigational drug candidate Pracinostat…

ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At Biotech Showcase In San Francisco

December 21, 2014 – 5:00 pm | Edit Post

SAN DIEGO and SAN FRANCISCO, Dec. 22, 2014 /PRNewswire/ –ViaCyte, Inc., a privately-held regenerative medicine company with the first stem cell-derived islet replacement therapy for the treatment of diabetes in clinical trials, today announced that Dr.

Apricus Biosciences Announces Year-End 2014 Update And 2015 Plans To Advance Its Clinical Pipeline And Further Commercialize Its Erectile Dysfunction Drug Vitaros

December 21, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 22, 2014 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reviewed its 2014 corporate progress and its clinical development and commercialization plans for 2015.

Can scientists clone a rhinoceros?

December 20, 2014 – 5:03 pm | Edit Post

San Diego-based team aims to create rhino sperm and embryos from specialized stem cells.

Can scientists clone a rhinoceros?

December 20, 2014 – 5:03 pm | Edit Post

San Diego-based team aims to create rhino sperm and embryos from specialized stem cells.

Isis Pharma soars on financial praise

December 19, 2014 – 10:00 am | Edit Post

Isis Pharma shares jump to another record high after financial personality touts stock.

Isis Pharma soars on financial praise

December 19, 2014 – 10:00 am | Edit Post

Isis Pharma shares jump to another record high after financial personality touts stock.